Enoxaparin (Lmwh) Suppliers & Bulk Manufacturers
Available Forms: Subcutaneous (SC) Prefilled Syringes/Injectables
Available Strengths: 30 mg, 40 mg, 40 mg/0.4 mL, 80 mg, 100 mg, 120 mg, 150 mg
Reference Brands: Lovenox(US), Clexane(EU)
Category: Blood Disorder
Enoxaparin is a low molecular weight heparin that inhibits factor Xa activity, reducing blood clot formation. It provides effective anticoagulation, preventing deep vein thrombosis, pulmonary embolism, and ischemic events. Its benefits include predictable dosing, fewer blood tests needed, and rapid onset, making it ideal for both treatment and prevention. Enoxaparin (LMWH) is available in Subcutaneous (SC) Prefilled Syringes/Injectables and strengths such as 30 mg, 40 mg, 40 mg/0.4 mL, 80 mg, 100 mg, 120 mg, 150 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Enoxaparin (LMWH) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Enoxaparin (LMWH) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Enoxaparin is regulated as a biosimilar or medicinal product in the EU and US. In the US, it is approved by the FDA, requiring a detailed dossier demonstrating bioequivalence, safety, efficacy, and manufacturing standards. In the EU, it is authorized through EMA approval, adhering to the biosimilar guidelines. Both regions demand rigorous quality controls, including pharmacovigilance and stability data. For comprehensive guidance on dossier preparation, regulatory pathways, and market entry strategies, visit PharmaTradz. Ensuring compliance with regional regulations is crucial for successful approval and commercialization of enoxaparin products worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Ferric Maltol
Strength:
30 mg
Form: Capsules
Reference Brands: Accrufer (USA), Feraccru (EU)
View DetailsLusutrombopag
Strength:
3 mg
Form: Tablets
Reference Brands: Mulpleta (USA), Mulpleo (EU)
View DetailsAnagrelide
Strength:
0.5mg, 1mg
Form: Capsules
Reference Brands: Agrylin (USA), Xagrid(EU)
View DetailsQuick Response Guaranteed | Verified Suppliers